Cardinal Health price target raised to $156 from $138 at Leerink
Leerink raised the firm’s price target on Cardinal Health (CAH) to $156 from $138 and keeps an Outperform rating on the shares. Q2 results ...
Strong Prescription Trend and Growing Specialty Business Add Fuel to Cardinal's Momentum
Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...